Related by context. All words. (Click for frequent words.) 69 anti angiogenic agents 67 anticancer therapy 67 immune modulating 67 immunosuppressive therapies 67 nucleoside analogs 67 mTOR inhibitors 67 beta interferons 67 microtubule inhibitor 67 antiplatelet therapies 66 uric acid lowering 66 VEGF inhibitors 66 CYT# potent vascular disrupting 66 thalidomide Thalomid 66 antimetabolite 66 somatostatin analogs 66 HCV protease inhibitors 66 kidney urologic 66 selective inhibition 66 Interferon alpha 66 immune modulatory 66 VDAs 66 Interferon beta 66 oral NSAIDs 65 myopathy rhabdomyolysis 65 gemcitabine Gemzar 65 liposomal formulation 65 gemifloxacin 65 rituximab Rituxan 65 pyridostigmine 65 Gleevec resistant 65 RISPERDAL ® 65 recurrent glioblastoma multiforme 65 somatostatin analogues 65 dasatinib Sprycel 65 antiemetics 65 hematopoietic malignancies 65 Xanafide 65 histone deacetylase inhibitor 65 chemotherapy induced neutropenia 64 paclitaxel Taxol ® 64 thrombolytic agents 64 Eraxis 64 potentially hepatotoxic 64 tamoxifen Nolvadex ® 64 interferon IFN 64 chemopreventive agents 64 erlotinib Tarceva 64 HuLuc# 64 therapeutic regimens 64 chemotherapeutic treatments 64 primidone 64 Fludara ® 64 alkylating agent 64 topical formulations 64 APTIVUS r 64 immunomodulators 64 topical retinoids 64 mitochondrial toxicity 64 LHRH antagonists 64 MGd 64 skeletal metastases 64 alpha interferons 64 Thalomid ® 64 EGFR inhibitors 64 drug zotarolimus 63 proteasome inhibitor 63 nephrotoxicity 63 cytotoxic therapies 63 hematopoietic cancers 63 erlotinib Tarceva ® 63 levodopa carbidopa 63 Vidaza ® 63 Evoltra ® 63 antiangiogenic agent 63 metastatic bone 63 Squalamine 63 biologic therapy 63 antiangiogenic therapy 63 xenograft models 63 antiangiogenic agents 63 Vidaza azacitidine 63 secondary hyperparathyroidism 63 OHR/AVR# 63 EGFR antibodies 63 EGFR tyrosine kinase inhibitors 63 GnRH agonists 63 neurotrophic 63 anti angiogenic drugs 63 metastatic neuroendocrine tumors 63 aspirin clopidogrel 63 myelosuppressive 63 DACH platinum 63 trastuzumab Herceptin ® 63 doxorubicin HCl 63 bortezomib Velcade 63 treating neuropathic pain 63 antiandrogen 63 mucositis 63 erythropoietic 63 TMP SMX 63 plasminogen activators 63 Oral mucositis 63 mycophenolate mofetil 63 calcineurin inhibitors 63 antidepressants SSRIs 63 anticholinergic agents 63 TLR9 agonists 63 AChE inhibitors 63 imatinib Gleevec 63 antiandrogens 63 PDE4 inhibitors 63 YONDELIS 63 chemotherapeutic agents 63 chemoresistance 63 cytoprotective 63 orally bioavailable mimics 63 sargramostim 63 CHOP chemotherapy 63 intravenous bisphosphonates 63 HER2 overexpression 63 AMPK activators 63 SERMs 62 thiazide diuretic 62 EGFRIs 62 TNF Tumor Necrosis Factor 62 protease inhibitors PIs 62 bone marrow suppression 62 Gleevec imatinib mesylate 62 cisplatin gemcitabine 62 antithrombotics 62 renal toxicity 62 HMG CoA reductase inhibitors 62 symptomatic paroxysmal AF 62 antimetabolites 62 antitumor effect 62 Myelodysplastic syndromes MDS 62 hematologic disorders 62 endothelin receptor antagonists 62 Neulasta ® 62 JAK inhibitors 62 sorafenib Nexavar 62 neovascular 62 PARP inhibition 62 relapsed ovarian cancer 62 immunotoxins 62 vascular disrupting agents 62 dopaminergic therapy 62 Revlimid lenalidomide 62 lipid lowering agents 62 fibrotic disease 62 Velcade bortezomib 62 Vaprisol 62 anticancer therapies 62 chemotherapeutic drug 62 paclitaxel Taxol 62 immune dysregulation 62 nephrotoxic 62 pro angiogenic 62 isoproterenol 62 trans retinoic acid 62 Warfarin Coumadin 62 demonstrated antitumor activity 62 FUSILEV enhances 62 Orally administered 62 cytostatic 62 efalizumab 62 immunosuppressive agents 62 Atypical antipsychotics 62 corticosteroid therapy 62 Effexor venlafaxine 62 HDACi 62 effector function 62 endocrine therapies 62 Noxafil 62 immunosuppressive regimens 62 menadione 62 anti epileptics 62 vinorelbine 62 bevacizumab Avastin ® 62 immune modulator 62 immunomodulatory 62 gemcitabine Gemzar ® 62 LNP formulations 62 relapsed MM 62 daunorubicin 62 LHRH agonist 62 post herpetic neuralgia 62 CB1 antagonists 62 oxaliplatin Eloxatin 62 pegylated liposomal doxorubicin 62 benign prostatic hypertrophy BPH 62 alefacept 62 haematologic 62 epithelial tumors 62 biologic DMARD 62 lichen planus 62 xanthine oxidase inhibitor 62 VAPRISOL 62 lenalidomide dexamethasone 62 pegylated IFN 62 betamethasone dipropionate 62 postoperative ileus 62 Mitoxantrone 62 antiepileptics 62 chemotherapies 62 antihypertensive agents 62 Nilotinib 62 Pertuzumab 62 antiplatelet drugs 62 microtubule targeting 62 candidemia 62 pharmacologic therapies 62 bexarotene 62 Adjuvant chemotherapy 62 myeloproliferative diseases 62 neutropaenia 62 neuro protective 62 antisense inhibitors 62 synthetic retinoid 62 alpha interferon 62 taxane chemotherapy 62 neovascular diseases 62 thromboembolic disease 62 liposome encapsulated 62 oncological indications 62 lipid lowering therapies 62 immunomodulation 62 MYLOTARG 62 pertuzumab 61 NSAID induced 61 ophthalmic diseases 61 opioid analgesia 61 antihormonal 61 antiproliferative effects 61 pharmacologic treatments 61 Arcalyst 61 KL4 surfactant 61 GW# [003] 61 antithrombotic 61 proteasome inhibitors 61 inhaled bronchodilators 61 β blockers 61 Combination therapy 61 adalimumab Humira 61 MAGE A3 ASCI 61 NMDA antagonist 61 antitumour 61 invasive candidiasis 61 panitumumab Vectibix 61 Dasatinib 61 gemcitabine cisplatin 61 ONCASPAR 61 vidofludimus 61 cardiotoxic 61 metaglidasen 61 immunomodulating 61 hyperprolactinemia 61 vinca alkaloid 61 Rituxan rituximab 61 gefitinib Iressa 61 pouchitis 61 Vorinostat 61 anticoagulant warfarin 61 dyslipidemias 61 potent antiproliferative 61 monoclonal antibody therapies 61 Photodynamic therapy PDT 61 TLR antagonists 61 lumiliximab 61 intra abdominal infections 61 fusion enhancers 61 somatostatin analogue 61 TELINTRA 61 radionuclide therapy 61 topical corticosteroids 61 renoprotective 61 resolvins 61 standard chemotherapy regimens 61 antiarrhythmic 61 ADP receptor antagonist 61 tyrosine kinase inhibitors TKIs 61 osteosarcomas 61 PPAR gamma agonists 61 antianginal 61 anemias 61 anti androgens 61 immunomodulatory therapies 61 docetaxel Taxotere ® 61 radiochemotherapy 61 goserelin 61 Platinol ® cisplatin 61 neuroendocrine cancers 61 topical calcineurin inhibitors 61 CD# antibody [001] 61 Topical corticosteroids 61 myelofibrosis polycythemia vera 61 TLR9 agonist 61 inhibit platelet function 61 cisplatin chemotherapy 61 Amplimexon 61 dosing frequency 61 demethylating agent 61 Cytarabine 61 nonmelanoma skin cancers 61 deacetylase inhibitors 61 HDAC inhibition 61 Fc fusion protein 61 immune modulators 61 antidiabetic 61 antitumoral 61 Pyridorin 61 monoclonal anti 61 PAOD 61 MMP inhibitors 61 Paliperidone 61 hyperalgesia 61 hematologic toxicity 61 bendamustine 61 benign neoplasms 61 Rilonacept 61 enzyme inhibitors 61 antiplatelet medications 61 trastuzumab Herceptin R 61 Mitomycin C 61 receptor tyrosine kinase inhibitor 61 thymidylate synthase TS 61 Anticholinergic 61 MEK inhibitors 61 myelosuppression 61 vasodilators 61 CIPN 61 tumor subtypes 61 acetonide FA 61 agomelatine 61 chemotherapeutics 61 zoledronate 61 malignant pleural mesothelioma 61 Novantrone 61 BCG refractory 61 long acting bronchodilator 61 Ketotransdel TM 61 CellCept mycophenolate mofetil 61 leukotriene receptor antagonists 61 immunological diseases 61 diabetic kidney 61 G#DT 61 temsirolimus Torisel ® 61 antiarrhythmic drug 61 Beta catenin pathway 61 Cytotoxic 61 Tekamlo 61 selective modulator 61 Targretin capsules 61 PI3K inhibitor 61 nicotinic acid 61 chemoprotective 61 antidiabetic drugs 61 anticancer agents 61 mecamylamine 61 indolent NHL 60 lymphoma subtypes 60 proteasome inhibitor bortezomib 60 antiangiogenic 60 trabectedin 60 clevidipine 60 immunomodulatory therapy 60 micafungin 60 kallikrein 60 Symadex 60 azoles 60 indinavir 60 colorectal liver metastases 60 bacillus Calmette Guerin 60 antifungal agents 60 Myelofibrosis 60 vWD 60 hypervascular tumors 60 gastrointestinal motility 60 chemopreventive agent 60 metformin sulfonylurea 60 cytotoxics 60 antimitotic 60 Known hypersensitivity 60 intravenous cyclophosphamide 60 cidofovir 60 5FU 60 antiinflammatory 60 pegfilgrastim 60 Leukine ® 60 immunosuppressive regimen 60 imiquimod cream 60 liposomal doxorubicin 60 IL 1ß 60 etoposide 60 interleukin IL -# 60 inhibitor RG# 60 antitumor efficacy 60 infliximab Remicade 60 topical acne 60 griseofulvin 60 squamous cell carcinoma SCC 60 canakinumab 60 intranasal corticosteroids 60 hepatic encephalopathy HE 60 Hematologic 60 vitamin D analogs 60 tumor necrosis 60 heterozygous FH 60 neovascularisation 60 pemetrexed Alimta 60 biphosphonates 60 metastatic lymph nodes 60 standard chemotherapy regimen 60 Natalizumab 60 beta lactam antibiotic 60 targeted radiotherapeutic 60 serotonin reuptake inhibitor 60 viral kinetics 60 receptor agonists 60 idarubicin 60 KRAS status 60 haematologic malignancies 60 oral prodrug 60 systemic amyloidosis 60 Liprotamase 60 intra arterial chemotherapy 60 Bosentan 60 Xyfid TM 60 immunomodulatory effects 60 TKI therapy 60 azelaic acid 60 direct thrombin inhibitors 60 receptor inhibitor 60 ziconotide 60 LHRH agonists 60 trans retinoic acid ATRA 60 Surgical resection 60 Trastuzumab 60 NovaBay Aganocide compounds 60 denileukin diftitox 60 nadolol 60 rhIGF-I/rhIGFBP-3 60 Oral corticosteroids 60 aromatase inhibitors AIs 60 anti thrombotics 60 postoperative ileus POI 60 quinolone 60 GI motility disorders 60 FOSRENOL ® 60 IAP inhibitor 60 androgen ablation 60 tyrosine kinase inhibitor 60 immunosuppressives 60 investigational therapies 60 topical antifungal 60 postsurgical pain 60 urothelial cancer 60 forodesine 60 superficial bladder cancer 60 Th2 cytokines 60 synthetic analogues 60 NAGS deficiency 60 nucleoside analogues 60 FOLFIRINOX 60 Bcr Abl mutations 60 vasodilatory 60 Fibroblast Growth Factor Receptor 60 Campath alemtuzumab 60 ANCA associated 60 INVEGA ™ 60 seborrheic dermatitis 60 LHRH analogues 60 quetiapine Seroquel 60 ISTODAX 60 mTOR mammalian target 60 intradermal delivery 60 anti atherogenic 60 azacytidine 60 haematopoietic 60 HSP# inhibitor 60 chemoresistant 60 CA4P 60 conventional chemotherapies 60 antifolates 60 RoACTEMRA 60 acadesine 60 molecular biomarkers 60 SPRYCEL ® 60 anti emetics 60 infusional 60 photodynamic 60 recombinant erythropoietin 60 antiresorptive 60 cyclophosphamide methotrexate 60 dexamethasone Decadron 60 insulin sensitizing 60 pharmacological treatments 60 nonpharmacologic 60 Preclinical studies suggest 60 pimozide 60 tibolone 60 intradermal injection 60 Erlotinib 60 Sjögren syndrome 60 pegylated interferons 60 either acutely decompensated 60 constipation OIC 60 anti CD# antibodies 60 adriamycin 60 Parnate 60 treat chronic sinusitis 60 cytotoxic chemotherapy 60 tyrosine kinase inhibitors 60 multitargeted 60 synthase TS 60 prescribed proton pump 60 evaluating tivozanib 60 endometrial hyperplasia 60 ALGRX 60 chemotherapeutic drugs 60 ADVEXIN therapy 60 metastatic malignant 60 microwave hyperthermia 60 CYP#D# inhibitor 60 amifostine 60 pharmacological approaches 60 mTOR inhibition 60 Savella TM 60 Androgen deprivation therapy 60 LEP ETU 60 fluoropyrimidine 60 aripiprazole Abilify 60 biologic therapeutics 60 docetaxel Taxotere 60 Pemetrexed 60 QUADRAMET R 60 candidates Azedra TM 60 Platinol ® 60 thrombopoietin 60 Navelbine 60 thrombocytopenic patients 60 fibrate drugs 60 prostanoid 60 proliferative disorders 60 cutaneous squamous cell carcinoma 60 hypoxic tumors 60 CTAP# Capsules 60 CAPHOSOL 60 diabetic gastroparesis 60 candidate TNFerade biologic 60 Seliciclib 60 potent anti angiogenic 60 recurrent genital herpes 60 novel VDA molecule 60 Adenoscan 60 lapatinib Tykerb 60 conventional DMARDs 60 ACE inhibitor ramipril 60 Modrenal 60 oral mTOR inhibitor 60 thetreatment 60 receptor subtypes 60 antiapoptotic 60 diaper dermatitis 60 HbF 60 Camptosar ® 60 DCVax R 60 potency selectivity 60 pegylated interferon alfa 60 inhaled corticosteroid therapy 60 malignant ascites 60 Nonsteroidal anti inflammatory 60 #HT#A 60 busulfan 60 NSAID induced GI 60 plasma kallikrein inhibitor 60 ritonavir boosted 60 antiangiogenic drugs 60 superficial basal cell carcinoma 60 Radical prostatectomy 60 HIF PH inhibitors 60 Insulin detemir 60 H2 receptor antagonists 60 gastrointestinal stromal tumors GISTs 60 vinca alkaloids 60 thiazide 60 delipidation 60 Fibrates 60 raloxifene Evista 60 reslizumab 60 Vidofludimus 60 neoplastic diseases 60 PEGPH# 59 anti androgen 59 L asparaginase 59 DOXIL 59 echinocandins 59 CYP #A# 59 granisetron 59 Doxil ® 59 K ras mutations 59 Gefitinib 59 Radiofrequency ablation 59 fluconazole resistant 59 potent cytotoxic 59 immunostimulatory 59 nonalcoholic steatohepatitis NASH 59 immunomodulator 59 fulvestrant 59 tiagabine 59 BRAF inhibitors 59 myeloablative 59 mu opioid receptor antagonist 59 prokinetic 59 pharmacokinetic interactions 59 anti fibrotic 59 antimuscarinic 59 monoclonal antibody therapeutics 59 chronic periodontitis 59 tigecycline 59 prodrugs 59 entacapone 59 pancreatic NET 59 non metastatic osteosarcoma 59 Serdolect ® 59 LAB CGRP 59 osteoclast activity 59 cardiometabolic disorders 59 improves glycemic 59 atrial tachyarrhythmias 59 pan HDAC inhibitor 59 cilengitide 59 overlapping toxicities 59 subependymal giant cell 59 Topical treatments 59 CIMZIA R 59 trastuzumab Herceptin 59 chemotherapeutic regimens 59 post herpetic neuralgia PHN 59 octreotide 59 Fibromyalgia Syndrome FMS 59 Cloretazine 59 target enzyme thymidylate 59 Nexavar sorafenib 59 NMDA antagonists 59 ocular inflammatory 59 ENMD # 59 fludarabine cyclophosphamide 59 prokinetic agent 59 systemic corticosteroid 59 lomitapide 59 beta agonists 59 enzastaurin 59 protein tyrosine phosphatases 59 Systemic lupus erythematosus SLE 59 Erythropoietic therapies may 59 cartilage degeneration 59 phosphodiesterase inhibitors 59 tumor xenograft models 59 retinoid 59 Taxotere docetaxel 59 amphotericin B 59 Sporanox 59 flavopiridol 59 EFFEXOR XR 59 Diabetic nephropathy 59 interferon alfa 2b 59 pamidronate 59 Aptivus ® 59 novel emulsion formulation 59 Alpha lipoic acid 59 kinase inhibition 59 interferon alfa 59 hypercalcemia 59 oxybutynin 59 ACZ# 59 chemotherapeutic agent 59 antihypertensive therapy 59 risperidone Risperdal 59 DMARDS 59 sulphonylureas 59 Abatacept 59 mGluR2 59 Leydig cell 59 Anidulafungin 59 dextofisopam 59 Perforomist ™ Inhalation Solution 59 AAG geldanamycin analog 59 HGS ETR1 mapatumumab 59 rituximab Rituxan ® 59 leukemia AML 59 Pregabalin 59 convenient dosing regimens 59 surrogate endpoint 59 hypocalcaemia 59 beta emitting radioisotope 59 alfuzosin 59 sorafenib tablets 59 serotonin reuptake inhibitors 59 adverse cytogenetics 59 inhibiting tumor 59 inflammatory demyelinating 59 autoinflammatory diseases 59 cardiac allograft vasculopathy 59 imatinib resistance 59 Trandolapril 59 IGFBP 3 59 sorafenib Nexavar ® 59 CYP#A# inhibitors 59 Enkephalin 59 epoprostenol 59 hepatorenal syndrome 59 paroxetine Paxil 59 SIRT1 activators 59 Marqibo TM 59 non selective NSAIDs 59 bevacizumab Avastin 59 Fingolimod 59 Candida infection 59 targeted antifolate 59 peptide antigens 59 ixabepilone 59 cisplatin resistant 59 radiotherapy RT 59 Novartis Reclast 59 anticholinergic 59 beta adrenergic 59 mGluR2 NAM 59 growth hormone secretion 59 fluvastatin 59 palliative radiotherapy 59 OncoVEX 59 Tumor Necrosis Factor 59 Triptans 59 vWF 59 BeneFIX 59 sipuleucel T 59 BRAF inhibitor 59 esophagogastric 59 squamous cell lung cancer 59 systemic immunosuppressive drugs 59 HGS# 59 muscarinic 59 Inhaled nitric oxide 59 basal cell carcinoma BCC 59 ADPKD 59 Peginterferon alfa 2b 59 vildagliptin 59 visilizumab 59 Factor VIIa 59 inhaled anesthetics 59 humanized monoclonal 59 Platinol 59 lupus nephritis 59 prednisone prednisolone 59 multiple myeloma MM 59 cytotoxic 59 Saforis 59 hypertrophic scars 59 NOXAFIL 59 immunomodulatory properties 59 anti infective treatments 59 imatinib resistant 59 intravitreal injections 59 venlafaxine Effexor 59 idraparinux 59 cardiac repolarization 59 carbohydrate polymers 59 Zemiva TM 59 LLLT 59 mertansine 59 Parathyroid hormone 59 antiepileptic drugs AEDs 59 anticancer therapeutics 59 taxotere 59 Candida infections 59 Cremophor 59 eflornithine 59 durable remissions 59 tolterodine 59 protein misfolding diseases 59 antifibrotic 59 salmeterol fluticasone 59 chemosensitivity 59 ergot alkaloids 59 hA# 59 mineralocorticoid 59 cytoreduction 59 Calcitonin 59 Mucositis 59 proton pump inhibitors PPIs 59 teriflunomide 59 corticosteroid dexamethasone 59 IMiDs ® compound 59 dyslipidaemia 59 platelet inhibitor 59 Irinotecan 59 pharmacologic 59 Soliris eculizumab 59 levodopa therapy 59 signaling cascades 59 Chronic lymphocytic leukemia 59 small molecule activators 59 PI3K/mTOR 59 Pazopanib 59 antibody mediated 59 lysosomal storage diseases 59 efaproxiral 59 cinacalcet 59 radioprotective 59 antithrombotic therapy 59 triptan therapy 59 IV Busulfex 59 Zometa zoledronic acid 59 EXJADE 59 macrolide antibiotic 59 protein kinase inhibitor 59 AGHD 59 IL# PE 59 CD# antibodies 59 mapatumumab 59 A3 adenosine receptor 59 immuno modulatory 59 levodopa induced 59 hepatotoxic 59 neurological manifestations 59 R sorafenib tablets 59 docetaxel Taxotere R 59 Tasimelteon 59 Protein Kinase C 59 mGluR5 antagonist 59 SIADH 59 taxol 59 5 FU leucovorin 59 adrenal suppression 59 torsade de pointes 59 Cisplatin 59 Gleevec imatinib 59 hepatic cirrhosis 59 Fc receptor 59 adrenal hormone 59 emulsion formulation 59 glitazones 59 acne vulgaris 59 antiproliferative 59 tardive dyskinesia TD 59 immune suppressing 59 Taxotere chemotherapy 59 doxorubicin docetaxel 59 surgical debulking 59 murine models 59 rufinamide 59 recombinant interferon 59 myelination disorders 59 ovarian carcinoma 59 Febrile neutropenia 59 tolerability profiles 59 Epothilones 59 nucleoside analog 59 plasma kallikrein 59 paroxetine sertraline 59 bovine thrombin 59 neutropenic patients 59 mitomycin 59 BCR ABL inhibitors 59 sodium stibogluconate 59 Lenalidomide 59 lymphoid tumors 59 histone deacetylase HDAC 59 autoantibody levels 59 hepatic insufficiency 59 bleomycin 59 Y2 receptor 59 Onychomycosis 59 vorinostat 59 ACTEMRA TM 59 selective agonists 59 Friedreich Ataxia FRDA 59 dispersible tablet 59 hypereosinophilic syndrome 59 HepDirect prodrug 59 nucleotide analogs 59 Kepivance 59 protein tyrosine phosphatase 1B 59 neuroinflammatory 59 radiolabeled TM# 59 tizanidine hydrochloride short 59 interferon gamma 1b 59 beta lactam antibiotics 59 strong CYP#A# inducers 59 mutated K ras 59 urothelial bladder cancer 59 steroid dexamethasone 59 SGLT2 inhibitors 59 cardio renal 59 Sanvar R 59 Cimzia TM 59 Carvedilol 59 Pathway Inhibitor 59 Vectibix panitumumab 59 synthetic progestin 59 inhibits platelet aggregation 59 IMiDs 59 mycophenolic acid 59 Diovan HCT 59 dexrazoxane 59 tumor vascular disrupting 59 danazol 59 murine antibodies 59 oral levofloxacin 59 hepatocellular 59 herpetic keratitis 58 radiofrequency ablation RFA 58 Roche Xeloda 58 #ME# 58 docetaxel chemotherapy 58 omeprazole Prilosec 58 psychopharmacologic 58 neuropsychiatric diseases 58 etanercept Enbrel 58 Photodynamic therapy 58 PEGylated anti 58 cranial irradiation 58 ISF# 58 YONDELIS R 58 sunitinib malate 58 refractory angina 58 beta lactamase inhibitor 58 PI3K inhibitors 58 HeFH 58 cetuximab Erbitux ® 58 Aliskiren 58 metastatic RCC 58 pharmacologic intervention 58 insulin sensitizers 58 RECOTHROM R 58 Temporal lobe epilepsy 58 Carbamazepine 58 monoclonal antibody MAb 58 COMT inhibitors 58 PDGF receptor 58 Imiquimod 58 sulindac 58 immunosuppressive 58 infusional 5-FU/LV 58 tanespimycin 58 Taxol paclitaxel 58 clomipramine 58 PEGylated interferon 58 pharmacologically active isomer 58 LPM TM 58 Lamotrigine 58 Gliadel Wafer 58 adjunctively 58 FOLFOX6 chemotherapy regimen 58 chronic thromboembolic pulmonary 58 basilar migraine 58 antiepileptic 58 thrombolytic agent 58 zotarolimus 58 bone morphogenetic proteins BMPs 58 gastrointestinal toxicity 58 gastrointestinal stromal tumors GIST 58 neuroleptics 58 Danazol 58 Prostacyclin 58 uricase 58 nucleotide analog 58 Eplerenone 58 refractory gout 58 DexaSite 58 dermatological diseases 58 Pegylated interferon 58 anakinra 58 5-FU/LV 58 cardioprotection 58 signal transduction inhibitors 58 Xencor XmAb 58 mixed hyperlipidemia 58 conjugated estrogen 58 INVEGA ® 58 Riluzole 58 nonsteroidal 58 regorafenib 58 triglyceride lowering 58 bevacizumab Avastin Genentech 58 velafermin 58 anti thrombotic 58 act synergistically 58 Epidermal Growth Factor Receptor 58 RANK Ligand 58 CYP#A# substrate 58 Retinoic Acid 58 Anavex #-# 58 pharmacodynamic parameters 58 Tykerb lapatinib 58 Nexavar sorafenib tablets 58 metaplasia 58 protein kinase inhibitors